COVID-19 induced type 1 diabetes: A systematic review of case reports and series

Author:

Stathi Dimitra1ORCID,Triantafyllidis Konstantinos Katsikas2,Zafeiri Marina3,Karalliedde Janaka1,Kechagias Konstantinos S.4

Affiliation:

1. Department of Endocrinology and Diabetes, Guy's and St Thomas' NHS Foundation Trust, London, UK

2. Department of Nutrition and Dietetics, Homerton University Hospital Foundation Trust, London, UK

3. School of Cardiovascular Medicine and Sciences, King’s College London, London, UK

4. Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, UK

Abstract

Aims To provide an overview of reported cases of new-onset type 1 diabetes mellitus (T1D) following COVID-19 infection. Methods PubMed and Scopus library databases were screened for relevant case reports published between January 2020 and June 2022. Study design, geographic region or language were not restricted. Results Twenty studies were identified and involved 37 patients (20 [54%] male, 17 [46%] female). Median age was 11.5 years (range 8 months–33 years) and 31 (84%) patients were aged ≤17 years. Most patients (33, 89%) presented with diabetic ketoacidosis (DKA). In total, 23 (62%) patients presented at the time of positive COVID-19 testing and 14 (38%) had symptoms consistent with COVID-19 infection or a previous positive test (1–56 days). Diabetes symptomatology was provided in 22 cases and (19, 86%) reported polyuria, polydipsia, polyphagia, fatigue, or weight loss or a combination of the aforementioned in the preceding weeks (3 days–12 weeks). Of the 28 patients that had data on acute and long-term treatment, all recovered well and most were managed with basal bolus insulin regimens. Quality assessment showed that most reports were either ‘good’ or ‘moderate quality’. Conclusions Although uncommon, new-onset T1D is a condition healthcare professionals may expect to see following a COVID-19 infection.

Publisher

SAGE Publications

Subject

Biochemistry (medical),Cell Biology,Biochemistry,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3